发明公开
EP2734521A1 TETRAHYDROPYRIDO-PYRIDINE AND TETRAHYDROPYRIDO-PYRIMIDINE COMPOUNDS AND USE THEREOF AS C5A RECEPTOR MODULATORS
有权
四氢吡啶 - 吡啶和四氢吡啶 - 嘧啶化合物及其用作C5A受体调节剂的用途
- 专利标题： TETRAHYDROPYRIDO-PYRIDINE AND TETRAHYDROPYRIDO-PYRIMIDINE COMPOUNDS AND USE THEREOF AS C5A RECEPTOR MODULATORS
- 专利标题（中）： 四氢吡啶 - 吡啶和四氢吡啶 - 嘧啶化合物及其用作C5A受体调节剂的用途
-
申请号： EP12743023.9申请日： 2012-07-20
-
公开(公告)号： EP2734521A1公开(公告)日： 2014-05-28
- 发明人: GELIN, Christine , FLYER, Alec , ADAMS, Christopher, Michael , DARSIGNY, Veronique , HURLEY, Timothy, Brian , KARKI, Rajeshri, Ganesh , JI, Nan , KAWANAMI, Toshio , MEREDITH, Erik , SERRANO-WU, Michael, H. , RAO, Chang , SOLOVAY, Catherine , LEE, George, Tien-san , TOWLER, Christopher , HAR, Denis , SHEN, Lichun , HU, Bin , JIANG, Xinglong , CAPPACI-DANIEL, Christina
- 申请人： Novartis AG
- 申请人地址： Lichtstrasse 35 4056 Basel CH
- 专利权人： Novartis AG
- 当前专利权人： Novartis AG
- 当前专利权人地址： Lichtstrasse 35 4056 Basel CH
- 代理机构： Marti, Christiane
- 优先权： US201161510643P 20110722; US201161539732P 20110927
- 国际公布： WO2013016197 20130131
- 主分类号： C07D471/04
- IPC分类号： C07D471/04 ; A61K31/4375 ; A61K31/519 ; A61P27/02 ; A61P37/00
摘要：
The present invention provides a compound of formula I: (I) a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
公开/授权文献
信息查询
